Business Description
Anlon Healthcare Ltd
ISIN : INE0Y8W01025
Compare
Compare
Traded in other countries / regions
AHCL.India IPO Date
2025-09-03Description
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 13.36 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 18.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.2 | |||||
3-Year EBITDA Growth Rate | 62.6 | |||||
3-Year EPS without NRI Growth Rate | 77.6 | |||||
3-Year FCF Growth Rate | -244 | |||||
3-Year Book Growth Rate | 214.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.55 | |||||
9-Day RSI | 57.08 | |||||
14-Day RSI | 59.97 | |||||
3-1 Month Momentum % | 20.46 | |||||
6-1 Month Momentum % | -11.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.87 | |||||
Quick Ratio | 1.81 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 330.89 | |||||
Days Sales Outstanding | 251.05 | |||||
Days Payable | 117.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -11.46 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.68 | |||||
Operating Margin % | 29.04 | |||||
Net Margin % | 18.01 | |||||
EBITDA Margin % | 1061.15 | |||||
FCF Margin % | -83.59 | |||||
OCF Margin % | -57.29 | |||||
ROE % | 14.27 | |||||
ROA % | 8.66 | |||||
ROIC % | 17.16 | |||||
3-Year ROIIC % | 15.62 | |||||
ROC (Joel Greenblatt) % | 681.99 | |||||
ROCE % | 694.4 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 30.98 | |||||
PE Ratio without NRI | 30.98 | |||||
PS Ratio | 5.58 | |||||
PB Ratio | 3.73 | |||||
Price-to-Tangible-Book | 3.67 | |||||
EV-to-EBIT | 0.61 | |||||
EV-to-EBITDA | 0.61 | |||||
EV-to-Revenue | 6.55 | |||||
EV-to-FCF | -8.02 | |||||
Price-to-Graham-Number | 1.76 | |||||
| Price-to-Net-Current-Asset-Value | 5.13 | |||||
Earnings Yield (Greenblatt) % | 162.35 | |||||
FCF Yield % | -13.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anlon Healthcare Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,386.684 | ||
| EPS (TTM) (₹) | 0.521 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 59.97 | ||
| 14-Day ATR (₹) | 0.701983 | ||
| 20-Day SMA (₹) | 15.5835 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 9.078 - 17.275 | ||
| Shares Outstanding (Mil) | 531.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anlon Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anlon Healthcare Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2026-04-24 | 14.38 (-2.15%) |
Show
Entries
Anlon Healthcare Ltd Frequently Asked Questions
What is Anlon Healthcare Ltd(NSE:AHCL)'s stock price today?
The current price of NSE:AHCL is ₹15.90. The 52 week high of NSE:AHCL is ₹17.27 and 52 week low is ₹9.08.
When is next earnings date of Anlon Healthcare Ltd(NSE:AHCL)?
The next earnings date of Anlon Healthcare Ltd(NSE:AHCL) is .
Does Anlon Healthcare Ltd(NSE:AHCL) pay dividends? If so, how much?
Anlon Healthcare Ltd(NSE:AHCL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Anlon Healthcare Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers